Scholarlink

<p>Osteoporosis is a progressive skeletal disease involving bone tissue deterioration and a loss in bone mass. Primary osteoporosis affects older adults &gt; 70 years of age and is characterised by a sustained decline in bone mineral density and an increase in fracture risk. Pharmacological treatment comprises of anti-resorptive agents as first line therapy and anabolic agents for patients at very high fracture risk, used either individually or in sequential treatment. Non-pharmacological interventions to manage osteoporosis include calcium and vitamin D supplementation, lifestyle modifications, fall prevention strategies and structured exercise programmes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Treat osteoporosis in older adults with anti-resorptive and anabolic therapies to reduce fracture risk

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月9日

查看全文
  • Kimberley Chen

摘要

Osteoporosis is a progressive skeletal disease involving bone tissue deterioration and a loss in bone mass. Primary osteoporosis affects older adults > 70 years of age and is characterised by a sustained decline in bone mineral density and an increase in fracture risk. Pharmacological treatment comprises of anti-resorptive agents as first line therapy and anabolic agents for patients at very high fracture risk, used either individually or in sequential treatment. Non-pharmacological interventions to manage osteoporosis include calcium and vitamin D supplementation, lifestyle modifications, fall prevention strategies and structured exercise programmes.